Nalaganje...

Etiology and Management of Lack or Loss of Response to Anti–Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease

The management of patients with moderate to severe inflammatory bowel disease was transformed with the arrival of anti–tumor necrosis factor (TNF) therapy. Nevertheless, a considerable number of patients do not respond to anti-TNF induction therapy (primary nonresponse) or lose response to treatment...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Gastroenterol Hepatol (N Y)
Main Authors: Fine, Sean, Papamichael, Kostantinos, Cheifetz, Adam S.
Format: Artigo
Jezik:Inglês
Izdano: Millennium Medical Publishing 2019
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935028/
https://ncbi.nlm.nih.gov/pubmed/31892912
Oznake: Označite
Brez oznak, prvi označite!